|
Martinez-Sanchez MA, Ros-Madrid I, Fernandez-Ruiz VE, Cano-Marmol RP, Hernandez-Morante JJ, Nunez-Sanchez MA, Balaguer-Roman A, Frutos-Bernal MD, Ruiz-Alcaraz AJ, Queipo-Ortuno MI, Ferrer-Gomez M, Ramos-Molina B. Mid-Term Changes in Quality of Life and Nutritional Habits Following Gastric Bypass: A 24-Month Follow-Up Study. Nutrients. 2026 Jan 16;18(2):288. doi: 10.3390/nu18020288. PubMed PMID: 41599901.
AÑO: 2026; IF: 5.0
|
41599901
|
Flori L, Ramos-Molina B, Calderone V, Martelli A. Editorial: Targeting adipose tissue for the treatment of metabolic alterations. Front Pharmacol. 2026 Feb 11;17:1797423. doi: 10.3389/fphar.2026.1797423. eCollection 2026. No abstract available. PubMed PMID: 41756232; PubMed Central PMCID: PMC12932446.
AÑO: 2026; IF: 4.8
|
|
Gonzalez-Gonzalez A, Soria-Utrilla V, Fontalba-Romero MI, Nunez-Sanchez MA, Adarve-Castro A, Queipo-Ortuno MI, Ramos-Molina B, Martinez-Montoro JI, Fernandez-Garcia JC. The Role of Butyrate in People with Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Metabolic Comorbidities: A Systematic Review. Curr Obes Rep. 2026 Mar 4;15(1):17. doi: 10.1007/s13679-026-00694-8. No abstract available. PubMed PMID: 41779349.
AÑO: 2026; IF: 11.0
|
|
Rojo-Lopez MI, Nino-Narvion J, Antentas M, Fernandez-Camins B, Martinez-Rojo E, Poca M, Martinez-Sanchez MA, Ramos-Molina B, Rossell J, Mauricio D, Julve J. Niacin Derivatives in MASLD: Metabolic and Therapeutic Insights. Nutrients. 2026 Mar 20;18(6):996. doi: 10.3390/nu18060996. PubMed PMID: 41901171.
AÑO: 2026; IF: 5.0
|
|
Kuchay MS, Choudhary NS, Ramos-Molina B. Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease. Am J Physiol Cell Physiol. 2025 Apr 17. doi: 10.1152/ajpcell.00951.2024. Online ahead of print. PubMed PMID: 40244183.
AÑO: 2025; IF: 4.7
|